Results 61 to 70 of about 3,253 (256)
Archives of Endocrinology and Metabolism, 2016 Objective To compare the effects of a unique fixed combination levothyroxine/liothyronine (LT4/LT3) therapy in patients with primary hypothyroidism. Subjects and methods This is a randomized, double-blind, crossover study.
Juliana Kaminski +4 more
doaj +1 more source
Cytoskeletal protein Flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression [PDF]
, 2015 This work was supported by grant from DEBRA Australia to AJC and ZK. AJC is supported by the NHMRC Senior Research Fellowship (#1002009). ZK is supported by the NHMRC Early Career Fellowship (#1036509)
Alexander +53 more
core +2 more sources
The impact of hypothyroidism on satisfaction with care and treatment and everyday living:Results from E-mode patient self-assessment of thyroid therapy, a cross-sectional, international online patient survey [PDF]
, 2022 Background: Hypothyroid patients often report dissatisfaction and poor quality of life. This survey explored the impact of hypothyroidism on patient satisfaction, everyday living, experiences with health care professionals, and influence of demographic ...
Abad-Madroñero, Juan +9 more
core +2 more sources
British Journal of Clinical Pharmacology, EarlyView.Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran +2 more
wiley +1 more source
Mapping molluscan endocrinology: a systematic and critical appraisal
Biological Reviews, EarlyView.ABSTRACT Historically, a vertebrate‐centric paradigm has framed our interpretation of molluscan endocrinology, with considerable research focusing on vertebrate‐type steroid hormones (e.g. oestrogens, testosterone). However, contradictory evidence on the occurrence of vertebrate‐type steroid hormones in molluscan tissues, and a lack of the specific ...
Konstantinos Panagiotidis +3 more
wiley +1 more source
BMC Endocrine Disorders, 2022 Background Inconsistencies in the management of hypothyroidism have been reported among endocrinologists in different European countries. Aim of this study was to explore Czech endocrinologists’ use of thyroid hormones in hypothyroid and euthyroid ...
Jan Jiskra +8 more
doaj +1 more source
Socioeconomic influence on treatment with liothyronine and desiccated thyroid extract in Denmark
European Thyroid Journal, 2023 Introduction: High compared with low educational level increases the odds of starting levothyroxine (L-T4) with a normal thyroid-stimulating hormone – the mechanism is most likely patient request.
Jeppe Lerche la Cour +5 more
doaj +1 more source
Liothyronine (FK-300) in the Treatment of Male Infertility [PDF]
, 1961 1) L-Triiodothyronine (FK-300) was given to 12 patients of male infertility, 3 of azoospermia and 9 of oligospermia. There was an increase in sperm count observed in 8, a rise in sperm motility in 7, and the wife of the highly oligospermic men conceived.
原, 信二, 石神, 襄次
core
Levothyroxine and lung cancer in females: the importance of oxidative stress [PDF]
, 2013 BACKGROUND: Levothyroxine (LT(4)) treatment can lead to iatrogenic hyperthyroidism and oxidative stress that can cause patient discomfort. Oxidative stress is also recognized as one of the causes of chronic diseases and cancer. METHODS: The prevalence of
Annarosa Finco +3 more
core +1 more source
Role of selenium in the pathophysiology of cardiorenal anaemia syndrome
ESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai +2 more
wiley +1 more source